SOFIA, Bulgarien, 21. Juni 2023 /PRNewswire/ — Longbio Pharma (Suzhou) Co., Ltd. (abgekürzt „Longbio Pharma”), ein Pharmaunternehmen, das Medikamente zur Behandlung von Allergien, Asthma, Augenerkrankungen und anderen Autoimmunerkrankungen entwickelt, gab auf dem 29. Kongress der…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.